Aeolus Pharmaceuticals (AOLS)
(Delayed Data from OTC)
$0.00 USD
0 (0.00%)
Updated Jul 17, 2024 02:19 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Aeolus Pharmaceuticals Inc. [AOLS]
Reports for Purchase
Showing records 1 - 20 ( 20 total )
Company: Aeolus Pharmaceuticals Inc.
Industry: Medical - Drugs
Company: Aeolus Pharmaceuticals Inc.
Industry: Medical - Drugs
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Aeolus Pharmaceuticals Inc.
Industry: Medical - Drugs
Company: Aeolus Pharmaceuticals Inc.
Industry: Medical - Drugs
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Aeolus Pharmaceuticals Inc.
Industry: Medical - Drugs
Many Background Activities; Few Stock Catalysts; Rating to Neutral
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Aeolus Pharmaceuticals Inc.
Industry: Medical - Drugs
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Aeolus Pharmaceuticals Inc.
Industry: Medical - Drugs
F3Q12 Results; Steady Course for AEOL 10150 Work under BARDA Contract
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Aeolus Pharmaceuticals Inc.
Industry: Medical - Drugs
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Aeolus Pharmaceuticals Inc.
Industry: Medical - Drugs
Evidence of AEOL 10150 Neuroprotective Activity Against Nerve Agents
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Aeolus Pharmaceuticals Inc.
Industry: Medical - Drugs
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Aeolus Pharmaceuticals Inc.
Industry: Medical - Drugs
AEOL 10150 and Neupogen Appear to Synergize as Radioprotective Agents
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Aeolus Pharmaceuticals Inc.
Industry: Medical - Drugs
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Aeolus Pharmaceuticals Inc.
Industry: Medical - Drugs
F2Q12 Results; Driving Towards Potential EUA in 2013
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Aeolus Pharmaceuticals Inc.
Industry: Medical - Drugs
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Aeolus Pharmaceuticals Inc.
Industry: Medical - Drugs
BARDA''s Continued Confidence in AEOL 10150; Reiterate Buy
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Aeolus Pharmaceuticals Inc.
Industry: Medical - Drugs
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Aeolus Pharmaceuticals Inc.
Industry: Medical - Drugs
BARDA Nod for Additional $9.1 Million of ARS Funding
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Aeolus Pharmaceuticals Inc.
Industry: Medical - Drugs
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Aeolus Pharmaceuticals Inc.
Industry: Medical - Drugs
Company: Aeolus Pharmaceuticals Inc.
Industry: Medical - Drugs
ValuEngine Detailed Valuation Report for AOLS
Provider: VALUENGINE, INC
|